Skip to content

Clinical trials

Lung Diseases, Interstitial trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: United Kingdom Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20082
20091
20104
20123
20132
20143
20162
20178
20186
20193
20205
20216
20227
202311
20248
20256
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting18
Unknown status14
Active, not recruiting13
Terminated9
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim10
Royal Brompton & Harefield NHS Foundation Trust6
GlaxoSmithKline5
Imperial College London3
Insmed Incorporated3
University of Leicester3
Bristol-Myers Squibb2
Celgene2
Guy's and St Thomas' NHS Foundation Trust2
King's College Hospital NHS Trust2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial88
Idiopathic Pulmonary Fibrosis19
Pulmonary Fibrosis16
Pulmonary Disease, Chronic Obstructive12
Asthma9
Hypertension, Pulmonary7
Scleroderma, Diffuse7
Scleroderma, Systemic7
Fibrosis6
Lung Neoplasms6

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.